The International Tennis Integrity Agency (ITIA) today confirms that three tennis players have been provisionally suspended under the Tennis Anti-Doping Programme (TADP).
29-year-old Conner Huertas del Pino, from Peru, 24-year-old Mateo Barreiros Reyes, from Brazil, and 30-year-old Andrés Urrea, from Colombia, provided in-competition samples while competing in an ATP Challenger event in Bogota, Colombia, on 14 May 2025.
The samples were split into A and B samples and the subsequent analysis found that the players’ A samples contained boldenone, which is prohibited under the TADP, in the category of Anabolic Agents (section S1 [1.1] of the 2025 World Anti-Doping Agency Prohibited List). Boldenone is a non-Specified Substance, and none of the players possessed a valid TUE for the substance.
The ITIA sent each player a pre-charge notice of an Anti-Doping Rule Violation on 7 July 2025 under Article 2.1 of the TADP (presence of a Prohibited Substance in a Player’s Sample) and/or Article 2.2 (Use of a Prohibited Substance without a valid Therapeutic Use Exemption (TUE)).
Findings for non-Specified Substances carry a mandatory provisional suspension – effective in each player’s case from 7 July 2025.
Players have the right to apply to the Chair of the Independent Tribunal to lift their provisional suspensions. To date, none of the players have made such an application.
While provisionally suspended, Huertas del Pino, Barreiros Reyes and Urrea are prohibited from playing in, coaching at, or attending any tennis event authorised or sanctioned by the members of the ITIA (ATP, ITF, WTA, Tennis Australia, Fédération Française de Tennis, Wimbledon and USTA) or any national association.
The ITIA is an independent body established by its tennis members to promote, encourage, enhance, and safeguard the integrity of their professional tennis events.
Ends
Published 24 July 2025 16:30
